LIGAND PHARMACEUTICALS INCORPORATED (LGND) Gross profit 2016–2018
LIGAND PHARMACEUTICALS INCORPORATED (LGND) annual gross profit history from SEC filings — each fiscal year as reported.
$245.1MFY2018 · since FY2016: $103.4M → $245.1M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2018 | $245.1M | +80.6% |
| FY2017 | $135.7M | +31.3% |
| FY2016 | $103.4M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More LGND financial trends
LGND RevenueLGND Net incomeLGND Net marginLGND Gross marginLGND Operating incomeLGND Operating marginLGND Operating cash flowLGND Free cash flowLGND Capital expendituresLGND Return on equityLGND Stock buybacksLGND Dividends paidLGND Total assetsLGND Total liabilitiesLGND Shareholders’ equityLGND overview →